Chronic Granulomatous Disease (CGD) identification and carrier state detection by flow cytometric analysis of granulocyte respiratory burst

S. Bresciani, R. Badolato, R. Verardi, A. G. Ugazio, L. D. Notarangelo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chronic granulomatous disease includes a group of genetically inhereted diseases in which there is a reduced capacity of phagocytes to release union superoxide (O2 -) upon infection of cells with microrganisms or chemotactic factors. Diagnosis depend upon demonstration of reduced production of O2 - by neutrophils activated with phorbol-myrestate-acetate (PMA). Nitro blue tetrazolium (NBT) reduction test is the commonly used tecniquefor the identification of CGD patients. However, this method does not allow the identification of patients with variant-CGD that display a residual production of reactive oxygen. Recently, novel tests for the diagnosis of CGD (based on flow-cytometry analysis) have been introduced. We investigated anion superoxide production in PMA-activated neutrophils of 28 healthy adult donors, 30 children with the clinical suspect of CGD, and 5 of the X-linked form of CGD (X-CGD) by flow cytometric with dihydrorhodamine 123, NBT salts precipitation and dismutase-inhibitable cytochrome-c reduction. Each of these assays allowed correct identification of 5 CGD patients among 30 studied, although the NBT test failed to recognize a low production of O2 - in a patient then found affected from a variant form of the disease. These three diagnostic assays were then used to study anion superoxide release in neutrophils derived from 7 mothers or sisters of X-CGD patients. Interestingly, in one of the CGD carriers we found that about 6% of DHR-loaded granulocytes failed to respond to PMA stimulation, thus indicating that this subject was an X-CGD carrier as confirmed by mutational analysis of CYBB gene. In contrast, the both cytochrome- c reduction test and the NBT test failed to detect the carrier state in this subject. On the basis of our results we conclude that flow cytometric analysis of anion superoxide production by PMN, is an effective, rapid and accurate tool for diagnosis of Chronic Granulomatous Disease and allows precise identification of X-CGD-carrier.

Original languageEnglish
Pages (from-to)1029-1035
Number of pages7
JournalRivista Italiana di Pediatria
Volume23
Issue number6
Publication statusPublished - 1997

Fingerprint

Chronic Granulomatous Disease
Carrier State
Respiratory Burst
Granulocytes
Superoxides
Acetates
Neutrophils
Cytochromes c
Tetrazolium Salts
Chemotactic Factors
Phagocytes
Siblings
Flow Cytometry
Mothers
Tissue Donors
Oxygen

Keywords

  • Anion superoxide
  • Chronic Granulomatous Disease
  • Diagnosis, flow citometry
  • Neutrophils

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Chronic Granulomatous Disease (CGD) identification and carrier state detection by flow cytometric analysis of granulocyte respiratory burst. / Bresciani, S.; Badolato, R.; Verardi, R.; Ugazio, A. G.; Notarangelo, L. D.

In: Rivista Italiana di Pediatria, Vol. 23, No. 6, 1997, p. 1029-1035.

Research output: Contribution to journalArticle

Bresciani, S. ; Badolato, R. ; Verardi, R. ; Ugazio, A. G. ; Notarangelo, L. D. / Chronic Granulomatous Disease (CGD) identification and carrier state detection by flow cytometric analysis of granulocyte respiratory burst. In: Rivista Italiana di Pediatria. 1997 ; Vol. 23, No. 6. pp. 1029-1035.
@article{3617af317ccf4a2695bd0ba39b13af73,
title = "Chronic Granulomatous Disease (CGD) identification and carrier state detection by flow cytometric analysis of granulocyte respiratory burst",
abstract = "Chronic granulomatous disease includes a group of genetically inhereted diseases in which there is a reduced capacity of phagocytes to release union superoxide (O2 -) upon infection of cells with microrganisms or chemotactic factors. Diagnosis depend upon demonstration of reduced production of O2 - by neutrophils activated with phorbol-myrestate-acetate (PMA). Nitro blue tetrazolium (NBT) reduction test is the commonly used tecniquefor the identification of CGD patients. However, this method does not allow the identification of patients with variant-CGD that display a residual production of reactive oxygen. Recently, novel tests for the diagnosis of CGD (based on flow-cytometry analysis) have been introduced. We investigated anion superoxide production in PMA-activated neutrophils of 28 healthy adult donors, 30 children with the clinical suspect of CGD, and 5 of the X-linked form of CGD (X-CGD) by flow cytometric with dihydrorhodamine 123, NBT salts precipitation and dismutase-inhibitable cytochrome-c reduction. Each of these assays allowed correct identification of 5 CGD patients among 30 studied, although the NBT test failed to recognize a low production of O2 - in a patient then found affected from a variant form of the disease. These three diagnostic assays were then used to study anion superoxide release in neutrophils derived from 7 mothers or sisters of X-CGD patients. Interestingly, in one of the CGD carriers we found that about 6{\%} of DHR-loaded granulocytes failed to respond to PMA stimulation, thus indicating that this subject was an X-CGD carrier as confirmed by mutational analysis of CYBB gene. In contrast, the both cytochrome- c reduction test and the NBT test failed to detect the carrier state in this subject. On the basis of our results we conclude that flow cytometric analysis of anion superoxide production by PMN, is an effective, rapid and accurate tool for diagnosis of Chronic Granulomatous Disease and allows precise identification of X-CGD-carrier.",
keywords = "Anion superoxide, Chronic Granulomatous Disease, Diagnosis, flow citometry, Neutrophils",
author = "S. Bresciani and R. Badolato and R. Verardi and Ugazio, {A. G.} and Notarangelo, {L. D.}",
year = "1997",
language = "English",
volume = "23",
pages = "1029--1035",
journal = "Rivista Italiana di Pediatria",
issn = "0392-5161",
publisher = "Pacini Editore s.r.l.",
number = "6",

}

TY - JOUR

T1 - Chronic Granulomatous Disease (CGD) identification and carrier state detection by flow cytometric analysis of granulocyte respiratory burst

AU - Bresciani, S.

AU - Badolato, R.

AU - Verardi, R.

AU - Ugazio, A. G.

AU - Notarangelo, L. D.

PY - 1997

Y1 - 1997

N2 - Chronic granulomatous disease includes a group of genetically inhereted diseases in which there is a reduced capacity of phagocytes to release union superoxide (O2 -) upon infection of cells with microrganisms or chemotactic factors. Diagnosis depend upon demonstration of reduced production of O2 - by neutrophils activated with phorbol-myrestate-acetate (PMA). Nitro blue tetrazolium (NBT) reduction test is the commonly used tecniquefor the identification of CGD patients. However, this method does not allow the identification of patients with variant-CGD that display a residual production of reactive oxygen. Recently, novel tests for the diagnosis of CGD (based on flow-cytometry analysis) have been introduced. We investigated anion superoxide production in PMA-activated neutrophils of 28 healthy adult donors, 30 children with the clinical suspect of CGD, and 5 of the X-linked form of CGD (X-CGD) by flow cytometric with dihydrorhodamine 123, NBT salts precipitation and dismutase-inhibitable cytochrome-c reduction. Each of these assays allowed correct identification of 5 CGD patients among 30 studied, although the NBT test failed to recognize a low production of O2 - in a patient then found affected from a variant form of the disease. These three diagnostic assays were then used to study anion superoxide release in neutrophils derived from 7 mothers or sisters of X-CGD patients. Interestingly, in one of the CGD carriers we found that about 6% of DHR-loaded granulocytes failed to respond to PMA stimulation, thus indicating that this subject was an X-CGD carrier as confirmed by mutational analysis of CYBB gene. In contrast, the both cytochrome- c reduction test and the NBT test failed to detect the carrier state in this subject. On the basis of our results we conclude that flow cytometric analysis of anion superoxide production by PMN, is an effective, rapid and accurate tool for diagnosis of Chronic Granulomatous Disease and allows precise identification of X-CGD-carrier.

AB - Chronic granulomatous disease includes a group of genetically inhereted diseases in which there is a reduced capacity of phagocytes to release union superoxide (O2 -) upon infection of cells with microrganisms or chemotactic factors. Diagnosis depend upon demonstration of reduced production of O2 - by neutrophils activated with phorbol-myrestate-acetate (PMA). Nitro blue tetrazolium (NBT) reduction test is the commonly used tecniquefor the identification of CGD patients. However, this method does not allow the identification of patients with variant-CGD that display a residual production of reactive oxygen. Recently, novel tests for the diagnosis of CGD (based on flow-cytometry analysis) have been introduced. We investigated anion superoxide production in PMA-activated neutrophils of 28 healthy adult donors, 30 children with the clinical suspect of CGD, and 5 of the X-linked form of CGD (X-CGD) by flow cytometric with dihydrorhodamine 123, NBT salts precipitation and dismutase-inhibitable cytochrome-c reduction. Each of these assays allowed correct identification of 5 CGD patients among 30 studied, although the NBT test failed to recognize a low production of O2 - in a patient then found affected from a variant form of the disease. These three diagnostic assays were then used to study anion superoxide release in neutrophils derived from 7 mothers or sisters of X-CGD patients. Interestingly, in one of the CGD carriers we found that about 6% of DHR-loaded granulocytes failed to respond to PMA stimulation, thus indicating that this subject was an X-CGD carrier as confirmed by mutational analysis of CYBB gene. In contrast, the both cytochrome- c reduction test and the NBT test failed to detect the carrier state in this subject. On the basis of our results we conclude that flow cytometric analysis of anion superoxide production by PMN, is an effective, rapid and accurate tool for diagnosis of Chronic Granulomatous Disease and allows precise identification of X-CGD-carrier.

KW - Anion superoxide

KW - Chronic Granulomatous Disease

KW - Diagnosis, flow citometry

KW - Neutrophils

UR - http://www.scopus.com/inward/record.url?scp=0012178771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0012178771&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0012178771

VL - 23

SP - 1029

EP - 1035

JO - Rivista Italiana di Pediatria

JF - Rivista Italiana di Pediatria

SN - 0392-5161

IS - 6

ER -